Science Explorer Back to mapMap
Discussion
Researcher · Princess Máxima Center · Netherlands

Mirjam E. Belderbos

Mirjam E. Belderbos publishes mostly in Hematology, Molecular Biology and Immunology, on topics such as Hematopoietic Stem Cell Transplantation, Single-cell and spatial transcriptomics and Acute Myeloid Leukemia Research.

ORCID 0000-0002-6164-2918 OpenAlex
World rank
#1,071,709
of 7,710,434 ranked researchers
Rank in Netherlands
#24,882
of 107,149
Works
134
Citations
2.2k
Citations per work
16.5
h-index
23
i10-index 31Top 19% in Hematology
Mirjam E. Belderbos

What does Mirjam E. Belderbos research?

Mirjam E. Belderbos's work is mostly in Medicine (31%), Biochemistry, Genetics and Molecular Biology (26%), Immunology and Microbiology (12%).

Life Sciences: 50 works · 37.6% of their workBiochemistry, Genetics and Molecular Biology: 35 works · 26.0% of their workMolecular Biology: 18 works · 13.2% of their workCancer Research: 11 works · 8.0% of their workGenetics: 6 works · 4.8% of their workImmunology and Microbiology: 16 works · 11.6% of their workImmunology: 16 works · 11.6% of their workEverything else: 43 works · 31.9% of their workHealth Sciences: 41 works · 30.5% of their workMedicine: 41 works · 30.5% of their workHematology: 30 works · 22.5% of their workPublic Health, Environmental and Occupational Health: 11 works · 8.0% of their workTHEIR WORKMirjam E.Belderbos134works
Life Sciences38%Health Sciences31%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3526.0%
    2. Immunology and Microbiology1611.6%
  2. Everything else4331.9%
    1. Medicine4130.5%
  1. 1Hematology22% of their works
  2. 2Molecular Biology13% of their works
  3. 3Immunology12% of their works
  4. 4Cancer Research8% of their works
  5. 5Public Health, Environmental and Occupational Health8% of their works
  6. 6Genetics5% of their works

Research topics

Which keywords describe Mirjam E. Belderbos's research?

The keywords of their largest research topics: Hematopoietic Stem Cells, Prognostic Factors, Bone Marrow Niche, Graft-versus-Host Disease, Single-Cell, Transcriptomics, Acute Myeloid Leukemia and AML.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Hematopoietic Stem Cells612 topics
  2. Prognostic Factors482 topics
  3. Bone Marrow Niche361 topic
  4. Graft-versus-Host Disease361 topic
  5. Single-Cell281 topic
  6. Transcriptomics281 topic
  7. AML251 topic
  8. Acute Myeloid Leukemia251 topic
  9. Acute Lymphoblastic Leukemia231 topic
  10. Childhood Cancer231 topic
  11. Cancer Genomics221 topic
  12. Mutational Signatures221 topic
  13. Bronchopulmonary Dysplasia111 topic
  14. Copy Number Variation111 topic
  15. Foxp3111 topic
  16. Genomic Rearrangements111 topic
  17. Preterm Infants111 topic
  18. TGF-ß111 topic

Where does Mirjam E. Belderbos work?

Mirjam E. Belderbos's main affiliation in the publication record is Princess Máxima Center, Netherlands.

How many publications and citations does Mirjam E. Belderbos have?

OpenAlex counts 134 works and 2,207 citations for Mirjam E. Belderbos, an h-index of 23, ranking #1,071,709 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mirjam E. Belderbos. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.